What question did this study set out to answer?

To correlate measured myeloma cell mass with presenting clinical features, therapeutic response, and survival in order to construct a functional clinical staging system for multiple myeloma.

September 1, 1975Cancer

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

View Full Paper

Ask AI

Bookmark

Authors

BDBrian G.M. DurieUniversity of London SSSydney E. SalmonOntario Institute for Cancer Research

Discussion

Member takes

Implication

Observational cohort study reveals that clinical markers accurately predict myeloma cell mass in multiple myeloma, establishing a reliable three-tier staging system for prognosis and treatment.

Key Points

To correlate measured myeloma cell mass with presenting clinical features, therapeutic response, and survival in order to construct a functional clinical staging system for multiple myeloma.
Evaluated 71 patients with multiple myeloma by quantifying myeloma cell mass per square meter of body surface area from monoclonal immunoglobulin (M-component) synthesis and metabolism.
Performed bivariate correlation and multivariate regression analyses comparing calculated tumor burden against clinical parameters, chemotherapy response, and survival duration.
Myeloma cell mass was accurately predicted by the extent of bone lesions, hemoglobin levels, serum calcium concentrations, and serum/urinary M-component levels.
Response to chemotherapy and patient survival correlated significantly with the measured total tumor cell burden.
Established a standardized three-stage clinical staging system and predictive multivariate regression equations to quantify tumor mass at baseline and track disease during follow-up.

Cite This Study

Durie et al. (1975) studied this question.

synapsesocial.com/papers/69d95e8d5e5bcb4e3b835d65 https://doi.org/10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u

View Full Paper

Ask AI

Bookmark

Implication

Observational cohort study reveals that clinical markers accurately predict myeloma cell mass in multiple myeloma, establishing a reliable three-tier staging system for prognosis and treatment.

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

Discussion

Member takes

Implication

Key Points

Cite This Study

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider